A median of 4 maintenance cycles was administered ( range , pemetrexed 1-44 ; mean SD 7.9 8.3 ; placebo 1-38 ; mean SD 5.0 5.2 ) , with 28 % of pemetrexed and 12 % of placebo patients receiving 10 maintenance cycles .